Evotec’s president and CEO resigns
According to the company, Mario Polywka, COO, and Klaus Maleck, CFO, will jointly lead the organization until a permanent successor is announced. Flemming Ornskov, chairman of the supervisory
Genprex has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for a patent related to the use of its Reqorsa Gene Therapy (quaratusugene ozeplasmid) in combination with either programmed cell death protein 1 (PD-1) or PD-L1 antibodies to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).